Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

001540.KQ

Strong BuyFull HouseFLAG

Ahn-Gook Pharmaceutical Co., Ltd. · Healthcare · South Korea · $91M · Avg Vol: $660K/d

100
StockRank
Get insider-trade alerts
Q
70
V
90
M
74
P/E (TTM)
16.2x
ROE
12.6%
D/E
0.4x
Dividend %
6.0%
AI CONVICTION THESIS

Ahn-Gook shows potential as a niche pharmaceutical player with strong momentum; however, the thesis is heavily reliant on quantitative valuation 'upside' from third-party tools rather than a clear articulation of a 'destination business' with shared scale economics. Monitoring for clearer proof of a durable moat.

COMPANY DESCRIPTION

Ahn-Gook Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products. The company's pharmaceutical products include Cinatura and Revo Tension. The company was founded in 1959 and is headquartered in Seoul, South Korea.

FINANCIAL SUMMARY (KRW)

Year2022202320242025CAGRTTM
Revenue205.4B233.7B271.1B306.9B14.3%347.4B
EPS (KRW)604.00114.001,482658.002.9%662.52
Shares11.4M11.4M11.4M11.4M0.0%11.4M
Debt20.0B17.7B77.7B73.1B54.0%78.6B
Equity154.8B152.1B165.7B165.4B2.2%
Op CF1.8B-1.3B4.9B45.7B194.5%39.6B
Inv CF6.4B17.2B-75.4B-12.4B
Fin CF-3.7B-5.1B57.2B-10.2B
Loading 1Y...
PRICE (1Y)-2.8%
7.397.988.589.179.77Aug 3Aug 25Sep 15
SMA 50SMA 200

Close
$7.50
RSI (14)
22.7
52W High
$10.04
From 52W High
0.7%

SCORE BREAKDOWN

Quality
70
ROIC
4.6%54.6
ROE
12.6%77.3
GP/Assets
83.3%96.6
Op. Margin
9.4%61.0
FCF/Assets
14.0%92.7
Piotroski
783.9
Int. Cover
3.8x48.3
D/E Ratio
0.43x32.0
Current Ratio
1.69x31.8
Value
90
P/E (TTM)
16.2x69.7
EV/EBITDA
4.0x95.0
P/FCF
3.2x96.7
P/B
0.7x92.5
P/S
0.3x95.7
Div Yield
6.0%95.7
Momentum
74
52W High %
75%59.1
RS 6M
9%73.1
SMA 50/200
1.19x87.2
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
N/A
Q Growth
173%90.7

FUNDAMENTALS

Market Cap
$91M
P/E (Forward)
Gross Margin
66.7%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 001540.KQ are excluded.

TickerCompanyMkt CapStockRankSignal
001540.KQAhn-Gook Pharmaceutical Co., Ltd.(you)$91M100Strong Buy
234080.KSJW Lifescience Corporation$128M93Strong Buy
016580.KSWhan In Pharm Co.,Ltd.$137M94Strong Buy
023910.KQDaihan Pharmaceutical Co.,Ltd.$116M89Strong Buy
096760.KSJW Holdings Corporation$209M100Strong Buy
005500.KSSamjin Pharmaceuticals Co., Ltd.$170M93Strong Buy
106190.KQHigh Tech Pharm Co., Ltd.$86M81Strong Buy
001630.KSChong Kun Dang Holdings Corp.$136M86Strong Buy
072020.KQChoong Ang Vaccine Laboratory Co., Ltd.$63M82Strong Buy
033270.KSKorea United Pharm Inc.$188M88Strong Buy

Peer medians: ROE -0.3% · P/E 16.1x · Gross margin 43.0%

Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ): Stock Score Summary

Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ) has a MoatMap StockRank of 100/100 based on Quality (70/100), Value (90/100), and Momentum (74/100) factor scores. The current signal is STRONG BUY. Ahn-Gook shows potential as a niche pharmaceutical player with strong momentum; however, the thesis is heavily reliant on quantitative valuation 'upside' from third-party tools rather than a clear articulation of a 'destination business' with shared scale economics. Monitoring for clearer proof of a durable moat.

Ahn-Gook Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products. The company's pharmaceutical products include Cinatura and Revo Tension. The company was founded in 1959 and is headquartered in Seoul, South Korea.

Key Financial Metrics

Price$7.50
Market Cap$91M
P/E (TTM)16.20
Price/Book0.73
Return on Equity12.6%
Return on Invested Capital4.6%
Debt/Equity0.43x
Gross Margin66.7%
Operating Margin9.4%
Revenue Growth19.6%
Dividend Yield6.0%
Free Cash Flow$29M

Ahn-Gook Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is Ahn-Gook Pharmaceutical Co., Ltd.’s (001540.KQ) StockRank?
MoatMap’s StockRank for Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ) is 100/100, with a Strong Buy signal. It is a composite of Quality (70), Value (90), and Momentum (74) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does Ahn-Gook Pharmaceutical Co., Ltd. have an economic moat?
Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ) has a Quality factor score of 70/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Ahn-Gook Pharmaceutical Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ) is Strong Buy, based on a StockRank of 100/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Ahn-Gook Pharmaceutical Co., Ltd. in?
Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (South Korea).